Skip to Main Content

Paper Details

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis
0
2023
Author NameAffiliation
Athos BousvarosBoston Children's Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2